JTL
TARA icon

Jupiter Topco LLC’s Protara Therapeutics TARA Stock Holding History

Jupiter Topco LLC’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Buy
+4,696,709
New +$22.3M 0.01% 683

Other funds holding TARA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.58% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jupiter Topco LLC's TARA Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Protara Therapeutics (TARA) in Q2 2026: 4,696,709 shares worth $17.9M. The stake represents 0.01% of the portfolio and ranks #683 among its holdings.

111 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Jupiter Topco LLC held 4,696,709 shares of Protara Therapeutics worth $17.9M as of Q2 2026.
  • Protara Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • Protara Therapeutics made up 0.01% of Jupiter Topco LLC's portfolio in Q2 2026, its #683 holding.
  • 111 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.